CASI Pharmaceuticals, Inc.
CASI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$39 | -$27 | -$40 | -$36 |
| Dep. & Amort. | $2 | $4 | $2 | $2 |
| Deferred Tax | $0 | $0 | $0 | -$5 |
| Stock-Based Comp. | $1 | $7 | $7 | $8 |
| Change in WC | $1 | -$8 | -$7 | -$3 |
| Other Non-Cash | $6 | $4 | $16 | $8 |
| Operating Cash Flow | -$29 | -$20 | -$21 | -$27 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$6 | -$16 |
| Net Acquisitions | -$1 | $0 | $0 | $0 |
| Inv. Purchases | -$1 | -$52 | -$7 | -$12 |
| Inv. Sales/Matur. | $14 | $44 | $38 | $0 |
| Other Inv. Act. | $0 | -$2 | $6 | $7 |
| Investing Cash Flow | $11 | -$10 | $31 | -$21 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$1 |
| Stock Issued | $15 | $0 | $0 | $33 |
| Stock Repurch. | $0 | -$0 | -$3 | $0 |
| Dividends Paid | -$1 | -$1 | $0 | $0 |
| Other Fin. Act. | $1 | $0 | $0 | -$2 |
| Financing Cash Flow | $15 | -$1 | -$3 | $30 |
| Forex Effect | -$1 | $1 | $2 | -$0 |
| Net Chg. in Cash | -$4 | -$30 | $8 | -$18 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $17 | $47 | $39 | $57 |
| End Cash | $13 | $17 | $47 | $39 |
| Free Cash Flow | -$29 | -$22 | -$27 | -$42 |